Suppliers / Medichem

Medichem

Spain 379 employees 3 duplicate records merged Updated 9 July 2026

Medichem is an API and finished-dose manufacturer based in Spain. It holds 27 active US drug master files. Its filings concentrate with DAV (Vietnam), FDA (GH) and AEMPS (ES). Its GMP standing is certified by EMA, AEMPS (ES) and US FDA. Its most recent recorded inspection, by US FDA, closed on 22 June 2023 as VAI.

27
active US DMFs
0
valid CEPs
4
registered plants 1 with an FDA FEI number
80
filings across 7 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
5 of 5 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 22 June 2023 VAI US FDA
  • 15 June 2018 VAI US FDA
  • 30 April 2015 NAI US FDA
  • 21 September 2012 NAI US FDA
  • 9 April 2009 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Gerona, Spain Not on file
Barcelona, Spain Not on file
Girona, Spain Not on file
Spain, Spain 3002807552

What they file, and where

Molecule Regulators Docs
Chlorhexidine US FDA 4
Brimonidine SFDA (Saudi Arabia), US FDA 3
Quetiapine SFDA (Saudi Arabia), US FDA 3
Cyclobenzaprine SFDA (Saudi Arabia), US FDA 2
Loxapine US FDA 2
Adapalene US FDA 1
Amoxapine US FDA 1
Auranofin PMDA (Japan) 1
Captopril US FDA 1
Cinacalcet SFDA (Saudi Arabia) 1
Show all 30 molecules on file
Clozapine US FDA 1
Felodipine US FDA 1
Fluvoxamine US FDA 1
Guanfacine US FDA 1
Ivacaftor US FDA 1
Lamotrigine US FDA 1
Mexiletine US FDA 1
Mirtazapine US FDA 1
Nepafenac US FDA 1
Paroxetine US FDA 1
Pazopanib US FDA 1
Pimecrolimus US FDA 1
Probucol PMDA (Japan) 1
Sunitinib Malate SFDA (Saudi Arabia) 1
Tamsulosin US FDA 1
Varenicline US FDA 1
Varenicline Tartarate SFDA (Saudi Arabia) 1
Vildagliptin SFDA (Saudi Arabia) 1
Voclosporin US FDA 1
マレイン酸エナラプリル PMDA (Japan) 1

Also appears on these molecule pages

Show 2 more molecule pages

Filings and GMP by regulator

Regulator Filings GMP certificates
DAV (Vietnam) 50 None
FDA (GH) 11 None
AEMPS (ES) 6 2
EMA 5 2
INFARMED (PT) 4 None
MINSA (CR) 2 None
US FDA None 1

Comparing suppliers?

Choose your molecules and target markets. Medichem comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • 42 active litigation matters are on record.
  • The most recent inspection outcome was VAI, on 22 June 2023.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates